McCabe MP, Sharlip ID, Atalla E, Balon R, Fisher AD, Laumann E, et al. Defining sexual dysfunction in women and men: a consensus statement from the 4th International Congress on Sexual Medicine, 2015. J Sex Med. 2016;13:135–43.
Seyam RM, Albakry A, Ghobish A, Arif H, Dandash K, Rashwan H. Prevalence of erectile dysfunction and its correlates in Egypt: a community-based study. Int J Impot Res. 2003;15:237–45.
Ayta IA, McKinlay JB, Krane RJ. Likelihood of worldwide increase in erectile dysfunction from 1995 to 2025 and policy implications. BJU Int. 1999;84:50–6.
Le MH, Yeo YH, Li X, Li J, Zou B, Wu Y, et al. 2019 Global prevalence of NAFLD: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2022;20:2809–17.e28.
Arshad T, Golabi P, Henry L, Younossi ZM. Epidemiology of nonalcoholic fatty liver disease in North America. Curr Pharm Des. 2020;26:993–7.
Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62:S47–64.
Duell PB, Welty FK, Miller M, Chait A, Hammond G, Ahmad Z, et al. Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American Heart Association. Arterioscler Thromb Vasc Biol. 2022;42:e168–85.
Hawksworth DJ, Burnett AL. Nonalcoholic fatty liver disease, male sexual dysfunction, and infertility: a common association, a common problem. Sex Med Rev. 2020;8:274–85.
Yilmaz M, Odabas O, Karaaslan M, Guler OF, Toprak T, Bicer S, et al. Predicting the risk of erectile dysfunction in patients with nonalcoholic fatty liver disease. Andrologia. 2021;53:e14091.
Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence and risk factors for nonalcoholic fatty liver disease: the Dionysus Nutrition and Liver Study. Hepatology. 2005;42:44–52.
Ruhl CE, Everhart JE. Fatty liver indicators in the multiethnic US National Health and Nutrition Examination Survey. Aliment Pharmacol Ther. 2015;41:65–76.
Pan J, Hu Y, Pang N, Yang L. Association between dietary niacin intake and nonalcoholic fatty liver disease: NHANES 2003-2018. Nutrition. 2023;15:4128.
Golabi P, Paik J, Hwang JP, Wang S, Lee HM, Younossi ZM. Prevalence and outcomes of nonalcoholic fatty liver disease (NAFLD) among Asian American adults in the United States. Liver Int. 2019;39:748–57.
Available from: Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2023, https://wwwn.cdc.gov/nchs/nhanes/default.aspx.
Johnson CL, Dohrmann SM, Burt VL, Mohadjer LK. National Health and Nutrition Examination Survey: Sample Design, 2011–2014. Vital Health Stat 2. 2014;162:1–33.
Zipf G, Chiappa M, Porter KS, Ostchega Y, Lewis BG, Dostal J. National Health and Nutrition Examination Survey: Design and implementation, 1999–2010. Vital Health Stat 1. 2013;56:1–37.
Russo GI, Cimino S, Fragalà E, Privitera S, La Vignera S, Condorelli R, et al. Association between nonalcoholic fatty liver disease and benign prostatic hyperplasia/lower urinary tract symptoms: new findings from an Italian cross-sectional study. World J Urol. 2015;33:743–51.
Kim D, Yoo ER, Li AA, Tighe SP, Cholankeril G, Harrison SA, et al. Depression is associated with nonalcoholic fatty liver disease in US adults. Aliment Pharmacol Ther. 2019;50:590–8.
Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results from the Massachusetts Study of Male Aging. J Urol. 1994;151:54–61.
National Institutes of Health. Consensus Conference Statement on Impotence. Int J Impot Res. 1993;5:181–99.
Google Academic
Wang W, Ma Y, Chen J, Peng L, Gao X, Lin L, et al. The relationship between 2,4-dichlorophenoxyacetic acid and erectile dysfunction. Front Public Health. 2022;10:910251.
Gu X, Tang D, Xuan Y, Shen Y, Lu LQ. Association between nonalcoholic fatty liver disease and peripheral neuropathy in the US population, a cross-sectional study. Sci Rep. 2023;13:5304.
Ruan Z, Lu T, Chen Y, Yuan M, Yu H, Liu R, et al. Association between psoriasis and nonalcoholic fatty liver disease in US adult outpatients. JAMA Dermatol. 2022;158:745–53.
Hicks CW, Wang D, Windham BG, Selvin E. Association between peripheral neuropathy and erectile dysfunction in US men. Am J Med. 2021;134:282–4.
Farag YMK, Guallar E, Zhao D, Kalyani RR, Blaha MJ, Feldman DI, et al. Vitamin D deficiency is independently associated with higher prevalence of erectile dysfunction: National Health and Nutrition Examination Survey (NHANES) 2001-2004. Atherosclerosis. 2016;252:61-7.
Kani HT, Sener TE, Aykut UE, Demirtas CO, Keklikkiran C, Ergenc I, et al. Causes of erectile dysfunction in nonalcoholic fatty liver disease. Hepatol Forum. 2021;2:60–3.
Hasanain AFA, Mahdy RE, Mahran AMA, Safwat ASM, Mohamed AO, Abdel-Aal SM. Erectile dysfunction in patients with nonalcoholic fatty liver disease. Arab J Gastroenterol. 2017;18:21–4.
Zang G, Sun X, Sun Y, Zhao Y, Dong Y, Pang K, et al. Chronic liver disease and erectile dysfunction. Front Public Health. 2022;10:1092353.
Eren H, Horsanali MO. Independent association of nonalcoholic fatty liver disease with lower urinary tract symptoms/benign prostatic hyperplasia and erectile function scores. BJU Int. 2019;124:329–35.
Duman DG, Biçakci E, Çelikel Ç, Akbal C. Nonalcoholic fatty liver disease is associated with erectile dysfunction: a prospective pilot study. J Sex Med. 2016;13:383–8.
Kim Y, Chang Y, Cho YK, Ahn J, Shin H, Ryu S. Obesity and weight gain are associated with progression of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2019;17:543–50.e2.
Tada T, Toyoda H, Sone Y, Yasuda S, Miyake N, Kumada T, et al. Type 2 diabetes mellitus: a risk factor for progression of hepatic fibrosis in middle-aged patients with nonalcoholic fatty liver disease. J Gastroenterol Hepatol. 2019;34:2011–8.
Tejada ISD, Goldstein I, Azadzoi K, Krane RJ, Cohen RA. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle in diabetic men with impotence. N Engl J Med. 1989;320:1025–30.
Burnett AL, Lowenstein CJ, Bredt DS, Chang TS, Snyder SH. “Nitric oxide: a physiological mediator of penile erection.” Science. 1992;257:401–3.
Cunningham RP, Moore MP, Dashek RJ, Meers GM, Takahashi T, Sheldon RD, et al. A critical role for hepatocyte-specific eNOS in NAFLD and NASH. Diabetes. 2021;70:2476–91.
Persico M, Masarone M, Damato A, Ambrosio M, Federico A, Rosato V, et al. Nonalcoholic fatty liver disease and eNOS dysfunction in humans. BMC Gastroenterol. 2017;17:35.
Nozaki Y, Fujita K, Wada K, Yoneda M, Shinohara Y, Imajo K, et al. eNOS deficiency alters fat distribution and aggravates the pathology of early NAFLD. BMC Gastroenterol. 2015;15:177.
Duplain H, Burcelin R, Sartori C, Cook S, Egli M, Lepori M, et al. Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation. 2001;104:342–5.
O’Donnell AB, Araujo AB, Goldstein I, McKinlay JB. Validity of single-question self-report of erectile dysfunction. Results from the Massachusetts Male Aging Study. J Gen Intern Med. 2005;20:515–9.
